21 Jun 2024 --- Just one week after agreeing to pay US$700 million to settle an investigation brought forth by multiple US states, Johnson & Johnson (J&J) now faces yet another potential class action — this time, with claimants demanding damages and medical monitoring for women who were diagnosed with cancer or who may get the disease in the future. The claimants allege the cancer is a result of using J&J’s baby powder and other products containing talc. The proposed class action would be the first request for testing of female talc users in the US.
